Chronic obstructive pulmonary disease (COPD) is a manifestation of structural violence, the process through which societies ...

Johnson & Johnson has agreed a $850 million deal to acquire Proteologix that will give it a pair of early-stage bispecific antibodies ... treatment Dupixent (dupilumab) – approved for both ...

If approved, TSLP inhibitor tezepelumab could reach the market with a broader label than currently-used asthma antibodies ... Regeneron's IL-4/IL-13 inhibitor Dupixent (dupilumab) and AZ's ...

Medically reviewed by Brendan Camp, MD Hives and eczema are two of the most common skin disorders. Hives, clinically known as ...

The international consulting firm Clarivate makes its bet among the novelties ready for the medicine cabinet this year: three ...

No writing assistance was utilized in the production of this manuscript. Monoclonal antibodies are novel therapeutic agents used with great success in the treatment of rheumatoid arthritis (RA).

Jan. 13, 2025 — Scientists have found that a test to detect circulating tumor DNA can predict lung cancer ... Lung Cancer Test Predicts Survival in Early Stages Better Than Current Methods Jan ...

Recently, rituximab, a chimeric anti CD20 monoclonal antibody which induces B-cell depletion, has been shown to improve patients' survival, as early rituximab use results in higher disease remission ...

For example, a growing number of allergic patients (e.g., asthma, atopic dermatitis) are being treated with biologics that block the IL-4/IL-13 axis (e.g., dupilumab, an anti-IL-4Rα mAb) (82, 120).